Foundation Medicine, Inc.
We are investigating Foundation Medicine, Inc. (“FMI” or the “Company”) (FMI) relating to the proposed acquisition of the Company by Swiss healthcare company Roche Holding AG (“Roche”). As a result of the merger, FMI shareholders are only anticipated to receive $137.00 in cash for each FMI share they own.